Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CAMCEVI™ safely and effectively. See full prescribing information for CAMCEVI. CAMCEVI (leuprolide) injectable emulsion, for subcutaneous use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
CAMCEVI is indicated for the treatment of adult patients with advanced prostate cancer.
- generic_name
- leuprolide
- product_names
- leuprolide
- ndc
- 72851-042, 72851-042-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en